Beyond Air Files 8-K
Ticker: XAIR · Form: 8-K · Filed: Sep 8, 2025 · CIK: 1641631
| Field | Detail |
|---|---|
| Company | Beyond Air, Inc. (XAIR) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Beyond Air filed a routine 8-K, no major news.
AI Summary
Beyond Air, Inc. filed an 8-K on September 8, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Beyond Air, Inc. is meeting its regulatory reporting obligations, but it does not disclose any new material information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting purposes and does not contain any new material information or events that would inherently increase risk.
Key Players & Entities
- Beyond Air, Inc. (company) — Registrant
- AIT Therapeutics, Inc. (company) — Former Company Name
- KokiCare, Inc. (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing for Beyond Air, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits, as of September 8, 2025.
When was this 8-K report filed?
This 8-K report was filed on September 8, 2025.
What is the principal executive office address for Beyond Air, Inc.?
The principal executive office address for Beyond Air, Inc. is 900 Stewart Avenue, Suite 301, Garden City, NY 11530.
What is the company's telephone number listed in the filing?
The company's telephone number listed is (516) 665-8200.
Has Beyond Air, Inc. had previous company names?
Yes, Beyond Air, Inc. was formerly known as AIT Therapeutics, Inc. (name change effective January 17, 2017) and KokiCare, Inc. (name change effective May 7, 2015).
Filing Stats: 712 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2025-09-08 17:20:27
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 19KB
- 0001493152-25-012825.txt ( ) — 226KB
- xair-20250908.xsd (EX-101.SCH) — 3KB
- xair-20250908_lab.xml (EX-101.LAB) — 33KB
- xair-20250908_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEYOND AIR, Inc. Date: September 8, 2025 By: /s/ Steven A. Lisi Name: Steven A. Lisi Title Chief Executive Officer